ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic ...

Check the latest SOF IMO 2025 syllabus and exam pattern for Classes 1 to 12. Know section-wise topics, marking scheme, and ...

Check removed topics, updated syllabus, and deleted units to focus on key concepts for better preparation in the 2026 exams.

RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp.

RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...

New York City Mayor-Elect Zohran Mamdani, who defeated Andrew Cuomo on Tuesday, showed the Democratic Party how to win with ...

"Brightstar has a successful history of supporting the Texas Lottery, and we are pleased that our contract was extended," ...

In an exclusive interview, Mark White, Chief Executive Officer of Nexalin, will appear on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss Nexalin’s game-changing approach to mental ...

Responsible for Corporate Development, Investor Relations, Government Affairs –REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ...

ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Sm ...

Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.

Spinogenix received FDA authorization earlier this year for an Expanded Access Program, providing access to 200 ALS individuals ineligible for clinical trials in the United States. SPG302 has also ...